AEON Biopharma
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -19 | -20 | |
EBITDA | -11,774 | -5,481 | -2,511 |
EBIT | -11,793 | -5,501 | -2,530 |
Net Income | -11,793 | -37,137 | -4,538 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -2,636 | -4,712 | -2,596 |
Cash | 6,243 | 3,006 | 5,927 |
Basic Shares | 40,614 | 12,105 | 11,634 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -78 | ||
EBITDA | -16,224 | -27,727 | -52,488 |
EBIT | -16,302 | -27,824 | -52,556 |
Net Income | -39,222 | 42,005 | -52,556 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -17,312 | -20,292 | -35,890 |
Cash | 3,006 | 13 | 9,746 |
Basic Shares | 9,921 | 575 | 1,928 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.02 |
2026-03-31 | -$0.25 |
2025-12-31 | -$3.72 |
2025-09-30 | -$0.39 |